Overcoming Endosomal Barrier by Amphotericin B-Loaded Dual pH-Responsive PDMA-b-PDPA Micelleplexes for siRNA Delivery
Source abstract
Abstract
The endosomal barrier is a major bottleneck for the effective intracellular delivery of siRNA by nonviral nanocarriers. Here, we report a novel amphotericin B (AmB)-loaded, dual pH-responsive micelleplex platform for siRNA delivery. Micelles were self-assembled from poly(2-(dimethylamino)ethyl methacrylate)-block-poly(2-(diisopropylamino)ethyl methacrylate) (PDMA-b-PDPA) diblock copolymers. At pH 7.4, AmB was loaded into the hydrophobic PDPA core, and siRNA was complexed with a positively charged PDMA shell to form the micelleplexes. After cellular uptake, the PDMA-b-PDPA/siRNA micelleplexes dissociated in early endosomes to release AmB. Live cell imaging studies demonstrated that released AmB significantly increased the ability of siRNA to overcome the endosomal barrier. Transfection studies showed that AmB-loaded micelleplexes resulted in significant increase in luciferase (Luc) knockdown efficiency over the AmB-free control. The enhanced Luc knockdown efficiency was abolished by bafilomycin A1, a vacuolar ATPase inhibitor that inhibits the acidification of the endocytic organelles. These data support the central hypothesis that membrane poration by AmB and increased endosomal swelling and membrane tension by a "proton sponge" polymer provided a synergistic strategy to disrupt endosomes for improved intracellular delivery of siRNA.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacology, ‡Department of Radiation Oncology, and §Department of Otolaryngology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, United States
References (48)
Show source-provided references
1. Elbashir S. M. · Nature · 2001 · 411 · 49410.1038/35078107 ↗
2. Fire A. · Nature · 1998 · 391 · 80610.1038/35888 ↗
3. de Fougerolles A. · Nat. Rev. Drug Discovery · 2007 · 6 · 44310.1038/nrd2310 ↗
4. Hannon G. J. · Nature · 2004 · 431 · 37110.1038/nature02870 ↗
5. Pecot C. V. · Nat. Rev. Cancer · 2011 · 11 · 5910.1038/nrc2966 ↗
6. Juliano R. · Nucleic Acids Res. · 2008 · 36 · 415810.1093/nar/gkn342 ↗
7. Thomas M. · Adv. Drug Delivery Rev. · 2007 · 59 · 12410.1016/j.addr.2007.03.003 ↗
8. Whitehead K. A. · Nat. Rev. Drug Discovery · 2009 · 8 · 12910.1038/nrd2742 ↗
9. Green J. J. · Acc. Chem. Res. · 2008 · 41 · 74910.1021/ar7002336 ↗
10. Kang H. C. · Biomaterials · 2010 · 31 · 307110.1016/j.biomaterials.2010.01.001 ↗
11. Meyer M. · J. Am. Chem. Soc. · 2008 · 130 · 327210.1021/ja710344v ↗
12. Mok H. · Nat. Mat. · 2010 · 9 · 27210.1038/nmat2626 ↗
13. Wang X. L. · Bioconjugate Chem. · 2007 · 18 · 216910.1021/bc700285q ↗
14. Wang X. L. · Mol. Pharmaceutics · 2009 · 6 · 73810.1021/mp800192d ↗
15. Yu H. · Curr. Opin. Mol. Ther. · 2009 · 11 · 165
16. Boussif O. · Proc. Natl. Acad. Sci. U. S. A. · 1995 · 92 · 729710.1073/pnas.92.16.7297 ↗
17. Tzeng S. Y. · Biomaterials · 2011 · 32 · 540210.1016/j.biomaterials.2011.04.016 ↗
18. Hatakeyama H. · Biomaterials · 2011 · 32 · 430610.1016/j.biomaterials.2011.02.045 ↗
19. Pittella F. · Biomaterials · 2011 · 32 · 310610.1016/j.biomaterials.2010.12.057 ↗
20. Walker G. F. · Mol. Ther. · 2005 · 11 · 41810.1016/j.ymthe.2004.11.006 ↗
21. Endoh T. · Adv. Drug Delivery Rev. · 2009 · 61 · 70410.1016/j.addr.2009.04.005 ↗
22. Kwon E. J. · Bioconjugate Chem. · 2008 · 19 · 92010.1021/bc700448h ↗
23. Zhou K. · Angew. Chem., Int. Ed. · 2011 · 50 · 610910.1002/anie.201100884 ↗
24. Casey J. R. · Nat. Rev. Mol. Cell Biol. · 2010 · 11 · 5010.1038/nrm2820 ↗
25. Won Y. Y. · J. Controlled Release · 2009 · 139 · 8810.1016/j.jconrel.2009.06.031 ↗
26. Jain J. P. · Mol. Pharm. · 2011 · 8 · 20410.1021/mp100267k ↗
27. Binet A. · Biochem. J. · 1988 · 253 · 43510.1042/bj2530435 ↗
28. Kozmin S. A. · Nat. Chem. Biol. · 2008 · 4 · 1910.1038/nchembio0108-19 ↗
29. Garcia-Chaumont C. · Antisense Nucleic Acid Drug Dev. · 2000 · 10 · 17710.1089/oli.1.2000.10.177 ↗
30. Gary D. J. · ACS Nano · 2011 · 5 · 349310.1021/nn102540y ↗
31. Du J. · J. Am. Chem. Soc. · 2005 · 127 · 1280010.1021/ja054755n ↗
32. Bowman E. J. · Proc. Natl. Acad. Sci. U. S. A. · 1988 · 85 · 797210.1073/pnas.85.21.7972 ↗
33. Johnson L. S. · Mol. Biol. Cell · 1993 · 4 · 125110.1091/mbc.4.12.1251 ↗
34. Emans N. · Biophys. J. · 1995 · 69 · 71610.1016/S0006-3495(95)79947-7 ↗
35. Berezhna S. Y. · Proc. Natl. Acad. Sci. U. S. A. · 2006 · 103 · 768210.1073/pnas.0600148103 ↗
36. Andreoli T. E. · Kidney Int. · 1973 · 4 · 33710.1038/ki.1973.126 ↗
37. Plank C. · J. Biol. Chem. · 1994 · 269 · 1291810.1016/S0021-9258(18)99963-1 ↗
38. Papadopoulos S. · Biophys. J. · 2000 · 79 · 208410.1016/S0006-3495(00)76456-3 ↗
39. Benoit D. S. · Biomacromolecules · 2011 · 12 · 270810.1021/bm200485b ↗
40. Yezhelyev M. V. · J. Am. Chem. Soc. · 2008 · 130 · 900610.1021/ja800086u ↗
41. Miller D. K. · J. Cell Biol. · 1983 · 97 · 184110.1083/jcb.97.6.1841 ↗
42. Lomas H. · Faraday Discuss. · 2008 · 139 · 14310.1039/b717431d ↗
43. Tseng Y. C. · Adv. Drug Delivery Rev. · 2009 · 61 · 72110.1016/j.addr.2009.03.003 ↗
44. Huang H. W. · Phys. Rev. Lett. · 2004 · 92 · 19830410.1103/PhysRevLett.92.198304 ↗
45. Varkouhi A. K. · J. Controlled Release · 2011 · 151 · 22010.1016/j.jconrel.2010.11.004 ↗
46. Cao N. · Biomaterials · 2011 · 32 · 222210.1016/j.biomaterials.2010.11.061 ↗
47. Qiu L. Y. · Biomaterials · 2007 · 28 · 413210.1016/j.biomaterials.2007.05.035 ↗
48. Dong Y. · Cancer Res. · 2010 · 70 · 808810.1158/0008-5472.CAN-10-1418 ↗